Free shipping on all orders over $ 500

Pexelizumab

Cat. No. M24981

All AbMole products are for research use only, cannot be used for human consumption.

Pexelizumab Structure
Synonym:

h5G1. 1-SC

Size Price Availability Quantity
100ug USD 280 In stock
Free Delivery on orders over USD 500 Bulk Inquiry?

Quality Control & Documentation
Biological Activity

Pexelizumab (h5G1. 1-SC) is a humanized scFv monoclonal antibody directed against the C5 complement component. Pexelizumab inhibits apoptosis and leukocyte infiltration. Pexelizumab can be used for the research of cerebral IR injury and myocardial infarction.

Chemical Information
CAS Number 219685-93-5
Storage Please store the product under the recommended conditions in the Certificate of Analysis.
References

[1] Gen-Min Lin. Cardiovasc Hematol Disord Drug Targets. Pexelizumab, an Anti-C5 Complement Antibody for Primary Coronary Revascularization: A New Insight from Old Versions

[2] Jagruti A Patel, et al. Recent Pat Cardiovasc Drug Discov. Pexelizumab and its role in the treatment of myocardial infarction and in coronary artery bypass graft surgery: a review

[3] Manesh R Patel, et al. Drugs Today (Barc). Pexelizumab: a novel therapy for myocardial ischemia-reperfusion

[4] Per A Whiss. Curr Opin Investig Drugs. Pexelizumab Alexion

Related Complement System Products
Eculizumab

Eculizumab is a first-in-class recombinant humanized monoclonal antibody targeting complement protein C5. C5, which can only recognize humans, cannot bind to C5 of other species.

SB290157 trifluoroacetate salt

SB290157 is a selective antagonist of complement anaphylatoxin C3a receptor, a 74 amino acid proinflammatory peptide that is a potent chemotaxin for eosinophils, macrophages and mast cells.

JPE-1375

JPE-1375 is a complement C5a receptor 1 (C5aR1) antagonist. JPE-1375 effectively inhibits polymorphonuclear leukocyte mobilization (EC50=6.9 µM) and reduces TNF levels (EC50=4.5 µM) in mice.

Compstatin

Compstatinis is a 13-residue cyclic peptide, binds to complement component C3 and inhibits complement activation with IC50 of 12 μM. Compstatin exhibits exclusive specificity for primate C3s and does not bind either to C3s from lower mammalian species or to two structural homologs of C3, human C4 and C5.

Avacopan

Avacopan (CCX168) is a first-in-class, potent, selective and orally available complement 5a receptor (C5aR1 or CD88) antagonist with an IC50 of 0.1 nM.

  Catalog
Abmole Inhibitor Catalog




Keywords: Pexelizumab, h5G1. 1-SC supplier, Complement System, inhibitors, activators

All AbMole products are for research use only, cannot be used for human consumption or veterinary use. We do not provide products or services to individuals. Please comply with the intended use and do not use AbMole products for any other purpose.



Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2026 AbMole BioScience. All Rights Reserved.